Literature DB >> 30667502

Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.

Jeffrey B Schwimmer1,2, Patricia Ugalde-Nicalo1, Jean A Welsh3,4,5, Jorge E Angeles1, Maria Cordero3, Kathryn E Harlow1,2, Adina Alazraki6, Janis Durelle1, Jack Knight-Scott6, Kimberly P Newton1,2, Rebecca Cleeton3, Cynthia Knott7, Juna Konomi3, Michael S Middleton8, Curtis Travers9, Claude B Sirlin8, Albert Hernandez3, Ahlia Sekkarie5, Courtney McCracken4,9, Miriam B Vos3,4,5.   

Abstract

Importance: Pediatric guidelines for the management of nonalcoholic fatty liver disease (NAFLD) recommend a healthy diet as treatment. Reduction of sugary foods and beverages is a plausible but unproven treatment. Objective: To determine the effects of a diet low in free sugars (those sugars added to foods and beverages and occurring naturally in fruit juices) in adolescent boys with NAFLD. Design, Setting, and Participants: An open-label, 8-week randomized clinical trial of adolescent boys aged 11 to 16 years with histologically diagnosed NAFLD and evidence of active disease (hepatic steatosis >10% and alanine aminotransferase level ≥45 U/L) randomized 1:1 to an intervention diet group or usual diet group at 2 US academic clinical research centers from August 2015 to July 2017; final date of follow-up was September 2017. Interventions: The intervention diet consisted of individualized menu planning and provision of study meals for the entire household to restrict free sugar intake to less than 3% of daily calories for 8 weeks. Twice-weekly telephone calls assessed diet adherence. Usual diet participants consumed their regular diet. Main Outcomes and Measures: The primary outcome was change in hepatic steatosis estimated by magnetic resonance imaging proton density fat fraction measurement between baseline and 8 weeks. The minimal clinically important difference was assumed to be 4%. There were 12 secondary outcomes, including change in alanine aminotransferase level and diet adherence.
Results: Forty adolescent boys were randomly assigned to either the intervention diet group or the usual diet group (20 per group; mean [SD] age, 13.0 [1.9] years; most were Hispanic [95%]) and all completed the trial. The mean decrease in hepatic steatosis from baseline to week 8 was significantly greater for the intervention diet group (25% to 17%) vs the usual diet group (21% to 20%) and the adjusted week 8 mean difference was -6.23% (95% CI, -9.45% to -3.02%; P < .001). Of the 12 prespecified secondary outcomes, 7 were null and 5 were statistically significant including alanine aminotransferase level and diet adherence. The geometric mean decrease in alanine aminotransferase level from baseline to 8 weeks was significantly greater for the intervention diet group (103 U/L to 61 U/L) vs the usual diet group (82 U/L to 75 U/L) and the adjusted ratio of the geometric means at week 8 was 0.65 U/L (95% CI, 0.53 to 0.81 U/L; P < .001). Adherence to the diet was high in the intervention diet group (18 of 20 reported intake of <3% of calories from free sugar during the intervention). There were no adverse events related to participation in the study. Conclusions and Relevance: In this study of adolescent boys with NAFLD, 8 weeks of provision of a diet low in free sugar content compared with usual diet resulted in significant improvement in hepatic steatosis. However, these findings should be considered preliminary and further research is required to assess long-term and clinical outcomes. Trial Registration: ClinicalTrials.gov Identifier: NCT02513121.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30667502      PMCID: PMC6440226          DOI: 10.1001/jama.2018.20579

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  27 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

2.  Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.

Authors:  P Loria; L E Adinolfi; S Bellentani; E Bugianesi; A Grieco; S Fargion; A Gasbarrini; C Loguercio; A Lonardo; G Marchesini; F Marra; M Persico; D Prati; G Svegliati- Baroni
Journal:  Dig Liver Dis       Date:  2010-02-19       Impact factor: 4.088

3.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

4.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Patricia Belt; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

5.  Beverage intake, diabetes, and glucose control of adults in America.

Authors:  Todd Mackenzie; Blair Brooks; Gerry O'Connor
Journal:  Ann Epidemiol       Date:  2006-02-02       Impact factor: 3.797

6.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T.

Authors:  Takeshi Yokoo; Masoud Shiehmorteza; Gavin Hamilton; Tanya Wolfson; Michael E Schroeder; Michael S Middleton; Mark Bydder; Anthony C Gamst; Yuko Kono; Alexander Kuo; Heather M Patton; Santiago Horgan; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2011-01-06       Impact factor: 11.105

Review 7.  Dietary fructose in nonalcoholic fatty liver disease.

Authors:  Miriam B Vos; Joel E Lavine
Journal:  Hepatology       Date:  2013-05-01       Impact factor: 17.425

Review 8.  Artificial sweeteners: a systematic review of metabolic effects in youth.

Authors:  Rebecca J Brown; Mary Ann de Banate; Kristina I Rother
Journal:  Int J Pediatr Obes       Date:  2010-08

9.  Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.

Authors:  Jean A Welsh; Saul Karpen; Miriam B Vos
Journal:  J Pediatr       Date:  2012-10-17       Impact factor: 4.406

10.  Dietary patterns, insulin resistance, and incidence of type 2 diabetes in the Whitehall II Study.

Authors:  Sarah A McNaughton; Gita D Mishra; Eric J Brunner
Journal:  Diabetes Care       Date:  2008-04-04       Impact factor: 19.112

View more
  57 in total

Review 1.  Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.

Authors:  Johanna K DiStefano
Journal:  Cell Mol Life Sci       Date:  2020-06       Impact factor: 9.261

Review 2.  Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Taisa Kohut; Jennifer Panganiban
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

3.  Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction.

Authors:  Ana Andres-Hernando; David J Orlicky; Masanari Kuwabara; Takuji Ishimoto; Takahiko Nakagawa; Richard J Johnson; Miguel A Lanaspa
Journal:  Cell Metab       Date:  2020-06-04       Impact factor: 27.287

4.  Nonalcoholic Fatty Liver Disease in Children.

Authors:  Katherine F Sweeny; Christine K Lee
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-12

Review 5.  Molecular aspects of fructose metabolism and metabolic disease.

Authors:  Mark A Herman; Morris J Birnbaum
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

6.  Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial.

Authors:  Lingli Cai; Jun Yin; Xiaojing Ma; Yifei Mo; Cheng Li; Wei Lu; Yuqian Bao; Jian Zhou; Weiping Jia
Journal:  Front Med       Date:  2021-06-29       Impact factor: 4.592

7.  Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin.

Authors:  Deanna M Salter; Wei Wei; Pragati P Nahar; Emily Marques; Angela L Slitt
Journal:  Toxicol Sci       Date:  2021-07-16       Impact factor: 4.849

8.  Fructose and Uric Acid as Drivers of a Hyperactive Foraging Response: A Clue to Behavioral Disorders Associated with Impulsivity or Mania?

Authors:  Richard J Johnson; William L Wilson; Sondra T Bland; Miguel A Lanaspa
Journal:  Evol Hum Behav       Date:  2020-10-01       Impact factor: 4.178

9.  When the beverage is sweet, how does the liver feel?

Authors:  Dong Xi; Rohit Kohli
Journal:  Curr Treat Options Pediatr       Date:  2019-11-11

Review 10.  Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Authors:  Hannele Yki-Järvinen; Panu K Luukkonen; Leanne Hodson; J Bernadette Moore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-13       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.